Rebecca Boyer-Hernandez

Clinical Research Coordinator - Nurse

I completed my Bachelor’s degree in Nursing at the Université de Sherbrooke in Quebec. I subsequently worked as a Registered Nurse at Camp Carowanis, a camp for children living with type 1 diabetes, where I discovered my passion for this field. I recently joined Dr. Haidar’s research team, contributing to various clinical aspects of ongoing studies. I will soon begin work on a study investigating the effects of Tirzepatide in individuals living with type 1 diabetes who are using automated insulin delivery systems.

Catalina Magaña

Clinical Research Coordinator

I completed my undergraduate degree in Physiological Sciences at the University of California, Los Angeles (UCLA). During that time, I developed practical experience in diabetes care while working as medical staff at a summer camp for children with type 1 diabetes (T1D). After relocating to Montreal, I began working as a Clinical Research Coordinator in Dr. Haidar’s lab. I am currently coordinating a study examining ketone dynamics in adults with T1D who are taking empagliflozin, an SGLT2 inhibitor, through the use of a continuous ketone monitor (CKM), a novel device that measures ketone levels in real time. My interests lie in improving health outcomes and reducing the day-to-day burden of those living with T1D, and I hope to pursue a career in medicine with a focus on endocrinology.

Trang Quynh Tran

Administrative Coordinator

I provide administrative support to Dr. Haidar and oversee the operations of the lab including staffing, finance, equipment, supplies and more.

Natasha Alder

Master's Student

I completed my Honours Bachelor degree in Anatomy and Cell Biology at McGill University, where I gained foundational experience in cellular and structural biology though research in microbiology and cell trafficking. I am currently pursuing my master’s in Experimental Medicine in Dr. Haidar’s lab as a Clinical Research Coordinator. I currently lead the SEMPA clinical trial, a study evaluating the combined effects of semaglutide and empagliflozin on glucose control and ketone dynamics in adults with type 1 diabetes. My interests centre on improving therapeutic tools, easing the burden of diabetes management and advancing translational research that directly informs patient care.

Carolyn Wright

Master's Student

I completed my bachelor’s degree at McGill University, majoring in pharmacology with a minor in neuroscience. I am now pursuing my master’s in experimental medicine, where I have the opportunity to bridge my pharmacological background with patient-centred research. In Dr. Haidar’s lab, I coordinate a study involved with investigating the potential of semaglutide (Ozempic) to reduce the burden of carbohydrate counting in people with type 1 diabetes using automated insulin pump therapy.

Keddy Moise

Master's Student

I am an internist and M.Sc. student in Experimental Medicine at McGill University, focusing on diabetes technologies for type 1 diabetes in Dr. Haidar’s lab. My work examines automated insulin delivery systems and adjunctive therapies, including tirzepatide, with a particular interest in cardiovascular outcomes. Previously, I practiced internal medicine in Haiti, improving outpatient diabetes care and access to services. I aim to pursue a career that integrates clinical research with patient-centered care for chronic metabolic diseases.

Jessica Troughton

Clinical Research Coordinator

I am a Clinical Trial Coordinator in Dr. Haidar’s lab for the Empa 6-Months Study, a randomized controlled parallel trial investigating the effectiveness of empagliflozin in adults with T1D with sub-optimal glycemic outcomes. I completed my Honours B.Sc. in Pharmacology at McGill University in Dr. Lisa Münter’s lab. I am now pursuing a Master of Science (Applied) in Translational Biomedical Engineering, learning about the design, development, and commercialization of biomedical technologies.

Linden Perz

Master's Student

I completed my bachelor’s degree in Interdisciplinary Medical Sciences at the University of Western Ontario. Currently, I am in my final semester of a course-based master’s program in Translational Biomedical Engineering at McGill University. I will soon begin another master’s in Biomedical Engineering under the supervision of Dr. Haidar, where my research will focus on continuous ketone monitoring in individuals with type 1 diabetes, utilizing SGLT2 inhibitors as adjuncts to automated insulin delivery. In this capacity, I will be involved in the conduct and coordination of clinical trials, which will include participant recruitment, documentation, data collection, among other responsibilities.

Elisabeth Lawton

Undergraduate Student

I am a final-year McGill Bioengineering student motivated to apply engineering to improve diabetes care. In the Diabetes Technology Lab, I work on data analysis and insulin-optimization algorithms.

Dr. Michael Tsoukas

Adult Endocrinologist

Associate Professor in the Department of Medicine, Faculty of Medicine and Health Sciences, McGill University

Endocrinologist in the Division of Endocrinology and Metabolism, MUHC

Dr. Laurent Legault

Paediatric Endocrinologist

Associate Professor in the Department of Pediatrics, Faculty of Medicine and Health Sciences, McGill University

Paediatric endocrinologist in the Division of Endocrinology and Metabolism, MUHC

Head of the Diabetes Clinic from (2000 to 2011) and (2014-present)

Dr. Jean-François Yale

Adult Endocrinologist

Professor of Medicine in the Department of Medicine, Faculty of Medicine and Health Sciences, McGill University

Endocrinologist in the Division of Endocrinology and Metabolism, MUHC